Monte Rosa Therapeutics Inc (GLUE) Directors and Executive Officers - CSIMarket
CSIMarket
 
Monte Rosa Therapeutics Inc   (NASDAQ: GLUE)

Monte Rosa Therapeutics Inc

Officers & Directors


Edmund Dunn
VP, Corporate Controller

Christine Siu
Director

Skvarka
Director

Ali Behbahani
Director

Chandra P. Leo
Director

Markus Warmuth
President, Chief Executive Officer and Director

Alexander Mayweg
Director

Anthony Manning
Director

Kimberly L. Blackwell
Director

Andrew Schiff
Director ,

Monte Rosa Therapeutics Inc currently has 150 employees.

  News about Monte Rosa Therapeutics Inc Key Personnel

Monte Rosa Therapeutics Forges Ahead with Ambitious Milestones Despite Recent Stock Drops



Monte Rosa Therapeutics, a leading biotechnology company specializing in the development of novel small molecule therapies, recently provided a comprehensive corporate update, highlighting its key anticipated milestones for the year 2024. However, the company s shares experienced a decline of -2.21% over the past five trading days, signaling an underlying concern among investors. Furthermore, an accumulated net loss of $-133 million during the 12-month period ending in Q3 2023 has resulted in a significant negative return on investment (ROI) of -48.57%.
Despite these challenges, Monte Rosa Therapeutics remains committed to its mission of revolutionizing drug discovery and making significant adv...






GLUE Management Effectiveness GLUE Revenue per Employee GLUE Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.